A randomized, placebo-controlled, double-blind study on the effects of (-)-epicatechin on the triglyceride/HDLc ratio and cardiometabolic profile of subjects with hypertriglyceridemia: Unique in vitro effects

Abstract Background Cardiometabolic disruptions such as insulin resistance, obesity, high blood pressure, hyperglycemia, and dyslipidemias, are known to increase the risk for cardiovascular and metabolic diseases such as type 2 diabetes mellitus and atherosclerosis. Several screening tools for asses...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of cardiology 2016-11, Vol.223, p.500-506
Hauptverfasser:	Gutiérrez-Salmeán, Gabriela, Meaney, Eduardo, Lanaspa, Miguel A, Cicerchi, Christina, Johnson, Richard J, Dugar, Sundeep, Taub, Pam, Ramírez-Sánchez, Israel, Villarreal, Francisco, Schreiner, George, Ceballos, Guillermo
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Cardiometabolic risk Cardiovascular Cardiovascular Diseases - blood Cardiovascular Diseases - drug therapy Cardiovascular Diseases - etiology Catechin - therapeutic use Cells, Cultured Cholesterol, HDL - blood Double-Blind Method Epicatechin Female Humans Hypertriglyceridemia - blood Hypertriglyceridemia - drug therapy Hypertriglyceridemia - etiology Male Metabolic syndrome Metabolic Syndrome - blood Metabolic Syndrome - drug therapy Metabolic Syndrome - etiology Middle Aged Nutraceutics Plasma triglycerides Risk Factors Triglyceride-HDL ratio Triglycerides - blood Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!